Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
07/24/2001
Lexicon Genetics Delivers Third Set of Discoveries to Bristol-Myers Squibb For New Drug Development
07/12/2001
Lexicon Genetics Closes Merger With Coelacanth Corporation
07/10/2001
Lexicon Genetics Expands Collaboration With Oriental Yeast Company in Japanese Drug Discovery Market
06/28/2001
Incyte Genomics and Lexicon Genetics Form Strategic Drug Discovery Alliance
06/26/2001
Lexicon Genetics President and CEO Arthur T. Sands Named Houston Region Entrepreneur of the Year in Health Sciences/Health Services
06/26/2001
Scientists at Lexicon Genetics Discover Gene That Functions to Maintain Filtration Barrier in Kidney
06/13/2001
Lexicon Genetics to Acquire Coelacanth Corporation
05/30/2001
Scientists Discover Function of Gene Controlling Growth of Head and Neck Cancer; Gene Knockouts Used to Describe Tumor Suppressor Gene
05/22/2001
Lexicon Genetics Announces Technology Sublicensing Program for Academic Research
05/08/2001
Lexicon Genetics Reports First Quarter 2001 Financial Results
«
Start
Prev
31
32
33
34
35
36
37
38
39
40
Next
End
»
Page 35 of 41
